A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.
This is the feed from
CNBC - Healthcare
Is this your feed? Claim it!
Publisher: Unclaimed!
Message frequency: 1.37 / day
Message History
Novo Nordisk CEO defended the company's decision to sue rival Eli Lilly over its weight-loss drug advertising.
Federal dollars in the two health insurance programs would not go toward gender-affirming care, but states could still cover the treatments.
The quarter wasn't totally clean, but strong profitability matters the most.
Doctors and other experts say that splitting the measles, mumps and rubella shot has no scientific basis and is unlikely to get off the ground.